Skip to main content
OpenTrials
Completed

NCT Number: NCT00827450

Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet

This study will assess

* whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans * whether the protective effect of coffee is dependent on it's antioxidant composition

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Centre d'investigations cliniques "cardiomet"/ CHUV

Lausanne, CH-1011, Switzerland

About this study

Epidemiological studies suggest that coffee consumption improves glucose homeostasis in insulin resistant subjects. An increase in intrahepatic lipids (hepatic steatosis) is highly prevalent in patients with the metabolic syndrome and may be used as a marker of altered hepatic lipid metabolism. Such an increased hepatic lipids content can be experimentally produced in healthy humans by a 6-day high fructose diet.

The purpose of this study is to evaluate whether coffee prevents hepatic lipid deposition in healthy male subjects fed a fructose-rich hypercaloric diet. Both caffeine and antioxidants (yet unspecified) may be involved.. To sort out the role of caffeine and antioxidants, we will test 3 different soluble coffee, ie fully torrefied decaffeinated coffee , partially torrefied decaffeinated coffee, and partially torrefied caffeinated coffee.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI between 19 and 15 kg/m2
  • less than 30 min physical activity /day
  • habitual coffee consumption less than three cupy /day
  • consumption of caffeine-containing sodas less than 2 servings/day
  • non-smoker

Exclusion criteria

  • consumption of alcohol more than 40g/day
  • presence of metallic foreign bodies
  • history of eye surgery
  • family history of diabetes mellitus
  • history of food intolerance
  • vegetarians

Treatment and study plan

Ctl

Dietary Supplement

Control, isocaloric diet; no coffee

High fructose diet; no coffee

Dietary Supplement

Hypercaloric, high fructose diet; no coffee

fully torrefied, caffeine-free coffee

Dietary Supplement

Hypercaloric, high fructose diet + coffee

partially torrefied, caffeine-free coffee

Dietary Supplement

Hypercaloric, high fructose diet + coffee

Partially torrefied, caffeinated coffee

Dietary Supplement

Hypercaloric, high fructose diet + coffee

Primary outcomes

  1. intra-hepatocellular lipid (IHCL) concentration

    Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement

Secondary outcomes

  1. fasting plasma triglycerides

    Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement

  2. fasting net lipid oxidation

    Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement

  3. fasting net carbohydrate oxidation

    Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement

  4. whole body ketone bodies turnover and oxidation (13C 3-hydroxybutyrate)

    Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement

  5. whole body glucose turnover (6,6 2H2 glucose)

    Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement

  6. whole body glycerol turnover (2H5 glycerol)

    Time frame: will be measured after 6 days on a hypercaloric, high fructose (4g/kg body weight/day) diet +/- treatement

Sponsors and collaborators

Lead sponsor

University of Lausanne

Other

Collaborators

  • Nestlé Research Center, Vers-chez-les-blanc, Switzerland

Registry information

Official study title

Effects of Coffees With Various Compositions of Antioxidants on Hepatic Steatosis Induced by a High Fructose, Hypercaloric Diet

Acronym: COLIBRI

Important dates

Study start
2009
Primary completion
2010
Study completion
2011
First posted
Jan 22, 2009
Registry last updated
Feb 24, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.